Ariad Pharmaceuticals (ARIA) Reports Q1 EPS In-Line
ARIA Hot Sheet
EPS Growth %: 0.0%Financial Fact:
Other income (expense), net: -15.91M
Today's EPS Names:
TARO, BRLI, TLB, More
Ariad Pharmaceuticals (Nasdaq: ARIA) reports Q1 EPS of ($0.26) versus the analyst estimate of ($0.26). Revenue for the quarter was $1.9 million, versus the consensus of $2.78 million.
Subscribe to EasyStockAlerts.com & Get real-time e-mail alerts when news hits your stocks!
Subscribe to EasyStockAlerts.com & Get real-time e-mail alerts when news hits your stocks!
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Patterson Companies, Inc. (PDCO) Tops Q4 EPS by 5c; Guides FY12
- Talbots, Inc. (TLB) Posts Surprise Q1 Profit; Comps Dip 3.8%
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
